A recent article from World of DTC Marketing spotlights findings from our 2026 Pharma AI Overviews Report, highlighting a major shift in patient behavior: AI is increasingly becoming the first stop for health information, reducing reliance on traditional search results and website visits. As tools like ChatGPT, Gemini, Perplexity, and Google’s AI Overviews deliver direct answers to health-related questions, the traditional search journey that pharma marketers have relied on for years is evolving.
The implications for pharma are substantial. Research shows that AI-generated answers are appearing for the vast majority of health-related searches, leading to fewer website visits and lower click-through rates. While referral traffic from AI platforms remains relatively small today, it is growing quickly, signaling a change that marketers can no longer ignore.
Our research found that 75% of non-branded pharma searches now trigger AI Overviews, signaling a major shift in how patients discover health information.
The takeaway?
Success may no longer be measured solely by “share of search” but instead by “share of answer.” Pharma brands will need to ensure their content is authoritative, easy for AI systems to interpret, and focused on delivering meaningful patient value. As AI becomes a primary source of health information, organizations must think not just about driving traffic, but about ensuring patients receive accurate, trustworthy answers wherever they search.
Download the 2026 AI Overviews Report below to explore the full findings and actionable guidance for navigating this new era with a GEO Action Plan.
Access the Report
Submit Your Details to Access the Content